[Federal Register Volume 64, Number 165 (Thursday, August 26, 1999)]
[Notices]
[Pages 46686-46687]
From the Federal Register Online via the Government Publishing Office [www.gpo.gov]
[FR Doc No: 99-22151]
-----------------------------------------------------------------------
DEPARTMENT OF HEALTH AND HUMAN SERVICES
Food and Drug Administration
[Docket No. 98D-0362]
Advisory Committee for Pharmaceutical Science Site-Specific
Stability Subcommittee; Notice of Meeting
AGENCY: Food and Drug Administration, HHS.
ACTION: Notice.
-----------------------------------------------------------------------
This notice announces a forthcoming meeting of a public advisory
committee of the Food and Drug Administration (FDA). The meeting will
be open to the public.
Name of Committee: Advisory Committee for Pharmaceutical Science
Site-Specific Stability Subcommittee.
General Function of the Committee: To provide advice and
recommendations to the agency on FDA's regulatory issues.
Date and Time: The meeting will be held on September 22, 1999, 8:30
a.m. to 5 p.m.
Location: Center for Drug Evaluation and Research Advisory
Committee Conference Room, 5630 Fishers Lane, Rockville, MD.
Contact Person: Kimberly Littleton Topper at Topperk@cder.fda.gov
or Angie Whitacre at Whitacrea@cder.fda.gov, Center for Drug Evaluation
and Research (HFD-21), Food and Drug Administration, 5600 Fishers Lane
Rockville, MD 20857, (301) 827-7001, or FDA Advisory Committee
[[Page 46687]]
Information Line, 1-800-741-8138 (301-443-0572 in the Washington, DC
area), code 12539. Please call the Information Line for up-to-date
information on this meeting.
Agenda: The subcommittee will discuss the March site-specific
stability proposal from the agency and the public comments submitted to
Docket No. 98D-0362.
Procedure: Interested persons may present data, information, or
views, orally or in writing, on issues pending before the committee.
Written submissions may be made to the contact person by September 8,
1999. Oral presentations from the public will be scheduled between
approximately 1 p.m. and 2 p.m. Time allotted for each presentation may
be limited. Those desiring to make formal oral presentations should
notify the contact person before September 8, 1999, and submit a brief
statement of the general nature of the evidence or arguments they wish
to present, the names and addresses of proposed participants, and an
indication of the approximate time requested to make their
presentation.
Notice of this meeting is given under the Federal Advisory
Committee Act (5 U.S.C. app. 2).
Dated: August 18, 1999.
Linda A. Suydam,
Senior Associate Commissioner.
[FR Doc. 99-22151 Filed 8-25-99; 8:45 am]
BILLING CODE 4160-01-F
